# Remote Ischemic Conditioning to Attenuate Myocardial Death and Improve Operative Outcome.

> **NCT03363958** · PHASE2 · UNKNOWN · sponsor: **Medinet Heart Centre** · enrollment: 80 (estimated)

## Conditions studied

- Coronary Artery Bypass
- Myocardial Reperfusion Injur
- Ischemic Preconditioning, Myocardial
- Ischemic Postconditioning

## Interventions

- **PROCEDURE:** Remote Ischemic Preconditioning with Postconditioning
- **PROCEDURE:** Sham RIPC procedure

## Key facts

- **NCT ID:** NCT03363958
- **Lead sponsor:** Medinet Heart Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363958, "Remote Ischemic Conditioning to Attenuate Myocardial Death and Improve Operative Outcome.". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03363958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*